Skip to main content
. 2018 Mar 20;131(6):643–647. doi: 10.4103/0366-6999.226892

Table 2.

Allele and genotype distributions of rs11129295 between MS and healthy controls

SNP Region Candidate Gene Genotype/Allele MS, n (%) HC, n (%) χ2 OR (95% CI) P
Stage 1
 rs11129295 Intergenic EOMES TT 91 (65.9) 157 (52.2) 10.251 0.005
CT 44 (31.9) 119 (39.5)
CC 3 (2.2) 25 (8.3)
T 226 (81.9) 433 (71.9) 10.022 1.764 (1.238–2.514) 0.002
C* 50 (18.1) 169 (28.1)
CT + TT 135 (97.8) 276 (91.7) 5.958 4.076 (1.209–13.739) 0.019
CC 3 (2.2) 25 (8.3)
TT 91 (65.9) 157 (52.2) 7.313 1.776 (1.169–2.769) 0.007
CT + CC 47 (34.1) 144 (47.8)
Stage 2
 rs11129295 Intergenic EOMES TT 26 (59.1) 97 (48.5) 6.336 0.020
CT 18 (40.9) 78 (39)
CC 0 (0) 25 (12.5)
T 70 (79.5) 272 (68.0) 4.586 1.830 (1.046–3.200) 0.030
C* 18 (20.5) 128 (32.0)
CT + TT 44 (100) 175 (87.5) 6.128 1.143 (1.085–1.204) 0.011
CC 0 (0) 25 (12.5)
TT 26 (59.1) 97 (48.5) 1.618 1.534 (0.791–2.973) 0.203
CT + CC 18 (40.9) 103 (51.5)
Stage 1 + 2
 rs11129295 Intergenic EOMES TT 117 (64.3) 254 (50.7) 17.452 4.17×10−5
CT 62 (34.1) 197 (39.3)
CC 3 (1.6) 50 (10.0)
T 296 (81.3) 705 (70.4) 16.378 1.834 (1.363–2.466) 5.19×10−5
C* 68 (18.7) 297 (29.6)
CT + TT 179 (98.4) 451 (90.0) 12.947 6.615 (2.037–21.481) 8.12×10−5
CC 3 (1.6) 50 (10.0)
TT 117 (64.3) 254 (50.7) 9.932 1.750 (1.233–2.484) 0.002
CT + CC 65 (35.7) 247 (49.3)

*The C allele is the ancestral allele according to dbSNP build 141; Analysis in a dominant model; Analysis in a recessive model. SNP: Single-nucleotide polymorphisms; MS: Multiple sclerosis; HC: Healthy controls. CI: Confidence interval; OR: Odds ratio.